Home / Education / Faculty Team / School of Basic Medical Sciences / Tenure-track Faculty / Immunology / Content

CHEN Xiaoying

Associate professor, Tsinghua University

Principal Investigator, Institute for Immunology, IDG/McGovern Institute for Brain Research, and Tsinghua-Peking Center for Life Sciences

Tsinghua University, Medical Science Building Room C115, 30. Shuang qing Road, Beijing, China, 100085

E-mail: xiaoyingchen@tsinghua.edu.cn

  • Education and Research Experience

  • Personal Profile

  • Research Areas

  • Honors and Awards

  • Selected Publications

  • Research Accomplishment

2025- Associate professor, Tsinghua University

Principal Investigator, IDG/McGovern Institute for Brain Research, Tsinghua-Peking

Center for Life Sciences, Institute for Immunology

2023-2025 Instructor, Washington University, School of Medicine

Department of Neurology

Neuroimmunology and approaches for the treatment of Alzheimer's disease

2019-2022 Postdoctoral fellow, lab of Dr. David Holtzman

Department of Neurology, Washington University, School of Medicine

APOE and immune response in Alzheimer's disease

2017-2019 Postdoctoral fellow, lab of Dr. Azad Bonni

Department of Neuroscience, Washington University, School of Medicine

Genetic and epigenetic regulations in learning in adult mammalian brain

2009-2016 PhD dissertation

Departments of Immunology, Neuroscience, Tongji University

David Geffen School of Medicine, UCLA

Neuronal development and maturation

Dr. Chen was a faculty member in the Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer’s Disease Research Center at Washington University School of Medicine.

Dr. Xiaoying Chen has contributed significant insights into understanding neuronal plasticity during development (2017, Journal of Neuroscience; 2016, 2020, Protein & Cell; 2020 Nature Communication), learning activities (2022, Nature), and neuron-immune interactions in neurodegenerative disease (2022, Immunity; 2023, Nature). She has received a number of honors and awards, including the Jeffrey L. Morby Prize for Best Research in Alzheimer’s Disease from Cure Alzheimer’s Fund (2024), the Early Career Achievement Award from Alzheimer’s Association (2023), the Career Development Award from the Society for Neuroscience (2023), the Coins for Alzheimer’s Research Trust from Rotary Foundation (2023), the O’Leary Prize for Best Neuroscience Research at Washington University (2022), the Poletsky Award for Alzheimer’s Disease Research from Washington University (2022), and the Tau Consortium Fellowship from Rainwater Charitable Foundation (2019).

She is a member of Society for Neuroscience, Alzheimer’s Association, American Society for Neurochemistry, American Neurological Association and International Society for Molecular Neurodegeneration. Dr. Chen has reviewed papers for journals, including Immunity, Nature Neuroscience, Alzheimer's & Dementia, Science Advances, Cell Reports, Molecular Neurodegeneration, Journal of Clinical Investigation, Journal of Neuroimmunology (Editorial board member), and Translational Neurodegeneration.

Alzheimer's disease is the most common neurodegenerative disorder. Pathologically, it is characterized by the aggregation of misfolded proteins, including extracellular deposition of amyloid-β (Aβ) as plaques and intracellular accumulation of aggregated tau as neurofibrillary tangles. The regional progression of brain atrophy in Alzheimer’s disease highly correlates with tau accumulation but not amyloid deposition, and the mechanisms of tau-mediated neurodegeneration remain elusive.

Innate immune responses represent a common pathway for the initiation and progression of some neurodegenerative diseases. So far, little is known about the extent or role of the adaptive immune response and its interaction with the innate immune response in the presence of amyloid-β or tau pathology. Our research first demonstrated that the adaptive immune response drives tau-mediated neurodegeneration and cognitive decline. These findings answer a fundamental question of how does tau aggregation lead to regional neuronal death. A deeper understanding of both innate and adaptive immune responses across the progression of AD is likely to reveal novel therapeutic strategies for both preclinical and clinically symptomatic stages of the disease.

My lab focuses on understanding the brain-body interactions in health and disease. Interdisciplinary approaches including, single-cell multi-omics, metabolisms, clarity imaging, in vivo calcium imaging, optogenetics, and in vivo CRISPR gene editing, are applied in understanding the dialogue of brain-immune communication and developing potential therapeutic tools. The major research directions in my lab are

1.Decoding the immune responses in Alzheimer’s disease and therapeutics development

2.Deciphering the brain-immune interface and brain-body interaction

3.Understanding neuronal plasticity throughout Alzheimer’s disease progression

2024 Jeffrey L. Morby Prize for Best Research in Alzheimer’s Disease, Cure Alzheimer’s Fund

2023 Early Career Achievement Award, Alzheimer's Association

2023 AAIC Advancements: Immunity Travel Award, Alzheimer's Association

2023 AAIC Advancements: APOE Travel Award, Alzheimer's Association

2022 Trainee Professional Development Award, Society of Neuroscience

2022 Brain Immunology and Glia Travel Award, Washington University School of Medicine

2022 Poletsky Award, Alzheimer’s Disease Research Center

2022 O’Leary Prize for Best Research in Neuroscience, Washington University

2017 Outstanding Research Scholarship, Tongji University

2015 Presidential Scholarship for Best Research, Tongji University

I-Neuron-immune interactions in Alzheimer’s disease

Alzheimer’s disease (AD) is the most common neurodegenerative disease, affecting millions of families worldwide. Pathologically, AD is characterized by protein aggregation, including extracellular amyloid-b (Ab) deposition as plaques and intracellular accumulation of aggregated tau as neurofibrillary tangles. The regional progression of brain atrophy in AD highly correlates with tau accumulation and the mechanisms of tau-mediated neurodegeneration remain elusive. Innate immune responses represent a common pathway for the initiation and progression of some neurodegenerative diseases. To date, little is known about the extent of the adaptive immune response in the presence of Aβ or Tau pathology. The contribution of the adaptive immune response to neurodegeneration and its interaction with innate immunity remains unknown. Our research first demonstrated that the adaptive immune response drives tau-mediated neurodegeneration and cognitive decline. These findings answer a fundamental question of how does tau aggregation lead to regional neuronal death. A deeper understanding of both innate and adaptive immune responses across the progression of AD is likely to reveal novel therapeutic strategies for both preclinical and clinically symptomatic stages of the disease. Targeting neuroinflammation therefore represents a promising therapeutic strategy to halt or slow disease progression, but therapeutic interventions should take into account the disease stage in order to target the appropriate pathophysiology.

Carling G, Fan L, Foxe N, Norman K, Wong M, Zhu D, Corona C, Razzoli A, Yu F, Yarahmady A, Ye P, Chen H, Huang Y, Amin S, Sereda R, Lopez-lee C, Zacharioudakis E, Chen X, Xu J, Cheng F, Gavathiotis E, Cuervo A, Holtzman D, Mok S, Sinha S, Sidoli S, Ratan R, Luo W, Gong S, Gan L. Alzheimer’s disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model. 2024. Neuron. 112. 1-20, PMID: 38328219

AAIC, Kloske C, Tansey M, Wilcock D (Chen X, leading the study of Microglia-mediated T-cell infiltration and reactivity) Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference. 2024. Alzheimer’s and Dementia. PMID: 39692624

AAIC, Kloske C, Bu G, Goate A, Holtzman D (Chen X, leading the study of APOE and immune response in Alzheimer’s Disease) Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference. 2024. Alzheimer’s and Dementia. 20, 5815-6664, PMID: 39031528

Chen X, Firulyova M, Manis M, Herz J, Smirnov I, Aladyeva E, Wang C, Bao X, Finn M, Hu H, Shchukina I, Kim M, Yuede C, Kipnis J, Artyomov M, Ulrich J, Holtzman D. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. 2023. Nature. 615, 668-677, PMID: 36890231

Chen X, Holtzman D. Emerging roles of innate and adaptive immunity in Alzheimer’s Disease. 2022. Immunity. 55, 2236-2254, PMID: 36351425

II-Genetic and epigenetic regulations in learning in adult mammalian brain

Cellular diversification is critical for specialized functions of the brain including learning and memory. Single-cell RNA sequencing facilitates transcriptomic profiling of distinct major types of neurons, but the divergence of transcriptomic profiles within a specific neuronal population and their link to function remain poorly understood. Using single cell multi-omics, in vivo calcium imaging, optogenetics, CRISPR knockout, and behavior analyses, I discovered a subpopulation neuron that specifically undergoes transcriptomic plasticity in response to neuronal activity and learning. Those findings answer the fundamental question of how diversification of neurons influences learning and memory and opens an entirely new and exciting direction of research in neuroscience for studying functional diversity in subtypes of neurons in response to environmental changes.

Chen X, Du Y, Broussard J, Kislin M, Yuede C, Zhang S, Dietmann S, Gabel H, Zhao G, Wang S, Zhang X, Bonni A. Transcriptomic mapping uncovers Purkinje neuron plasticity driving learning. 2022. Nature. 605, 722-727, PMID: 35545673

Chen X, Zhang B, Wang T, Bonni A, Zhao G. Robust principal component analysis for accurate outlier detection in RNA-Seq data. 2020. BMC Bioinformatics. 21, 269. PMID: 32600248

Chen X, Chanda A, Ikeuchi Y, Zhang X, Goodman JV, Reddy NC, Majidi SP, Wu DY, Smith SE, Godec A, Oldenborg A, Gabel HW, Zhao G, Bonni S, Bonni A. Transcriptional regulator SnoN promotes proliferation of cerebellar granule neuron precursors in the postnatal mouse brain. 2019. J Neurosci. 39, 44-62. PMID: 30425119

Smith SE, Chen X, Brier L, Bumstead J, Rensing N, Epstein A, Oldenborg A, Crowley J, Bice A, Dikranian

K, Ippolito J, Haigis M, Papouin T, Zhao G, Wong M, Culver JP, Bonni A.

Astrocyte deletion of α2-Na/K ATPase triggers episodic motor paralysis in mice via a metabolic pathway. 2020. Nature Communication. 11, 6164. PMID: 33268780

Krishnan N, Chen X, Donnelly-Roberts D, Mohler E.G, Holtzman D. M, Gopalakrishnan, S. M. Small molecule phenotypic screen identifies novel regulators of LDLR expression. 2020. ACS Chem Biol.15, 3262-3274. PMID: 33270420

III-Immune signaling in neuronal maturation

I studied the molecular and cellular mechanisms governing neuropsychiatric disorders by using functional subtype-specific neurons derived from human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs). I discovered that MeCP2-deficient human ESCs/iPSCs-derived neurons showed aberrant immature action potentials and synaptic transmission. To capture the molecular mechanisms governing neuron electrophysiological maturation at single cell level, I therefore developed electrophysiological recording coupled with single cell transcriptome analysis (Patch-Seq) and revealed a tight link between neuronal maturation and genes involved in ubiquitination, immune function, and oxidative phosphorylation.

Chen X*, Han X, Blanchi B, Guan W, Ge W, Yu YC*, Sun YE*. Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2. 2020. Protein Cell. 12, 639-652. PMID: 32851591 (co-corresponding author)

Chen X, Zhang K, Zhou L, Gao X, Wang J, Yao Y, He F, Luo Y, Yu Y, Li S, Cheng L, Sun YE.

Coupled electrophysiological recording and single cell transcriptome analyses revealed molecular mechanisms underlying neuronal maturation. 2016. Protein Cell. 7, 175-186. PMID: 26883038 (Cover research)

Chen Y, Yu J, Niu Y, Qin D, Liu H, Li G, Hu Y, Wang J, Lu Y, Kang Y, Jiang Y, Wu K, Li S, Wei J, He J, Wang J, Liu X, Luo Y, Si C, Bai R, Zhang K, Liu J, Huang S, Chen Z, Wang S, Chen X, Bao X, Zhang Q, Li F, Geng R, Liang A, Shen D, Jiang T, Hu X, Ma Y, Ji W, Sun YE. Modeling Rett Syndrome Using TALEN-Edited MECP2 Mutant Cynomolgus Monkeys. 2017. Cell. 169, 945-955. PMID: 28525759

Liu H, Chen Y, Niu Y, Zhang K, Kang Y, Ge W, Liu X, Zhao E, Wang C, Lin S, Jing B, Si C, Lin Q, Chen X, Lin H, Pu X, Wang Y, Qin B, Wang F, Wang H, Si W, Zhou J, Tan T, Li T, Ji S, Xue Z, Luo Y, Cheng L, Zhou Q, Li S, Sun YE, Ji W. TALEN-mediated gene mutagenesis in rhesus and cynomolgus monkeys. 2014. Cell Stem Cell. 14, 323-328. PMID: 24529597

Ten years scientific journey in filling the gap of neuron-immune interactions